A recent study underscores FoxO3′s pivotal role in lung fibrosis and hints at novel therapeutic avenues via FoxO3 manipulation.11The authors investigated ex-vivo-cultured fibroblasts from both human IPF lungs and bleomycin-treated mice. Here, FOXO3 is linked to idiopathic pulmonary fibrosis.